Status:
COMPLETED
Effectiveness and Safety of Lactobacillus Rhamnosus Lcr35® in the Treatment of Recurrent Aphthous Stomatitis
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Aphthous Stomatitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Recurrent aphthous stomatitis (RAS) is a frequent condition characterized by recurrent and painful oral ulcers with unknown pathophysiology. Recent studies suggest that a dysregulation of the oral mic...
Detailed Description
Recurrent aphthous stomatitis (RAS) is the most common chronic disease of the oral cavity, affecting 5-25% of the population. This condition is characterized by recurrent and painful oral ulcers. The ...
Eligibility Criteria
Inclusion
- 18 year-old or more
- Recurrent idiopathic aphtous stomatitis with at least one new lesion per month during the past 6 months.
Exclusion
- Symptomatic aphtosis associated with Crohn or Behcet disease
- Concomitant use of probiotic for any other reason
- Systemic use of colchicine or steroids or immunosuppressive drugs during the past 3 months
Key Trial Info
Start Date :
January 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02789605
Start Date
January 4 2018
End Date
July 15 2020
Last Update
November 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de NIce - Dermatologie
Nice, Alpes-Maritimes, France, 06200